The Canadian Centre on Substance Use and Addiction (CCSA) proudly welcomes Dr. Louis Francescutti, Neil Arao, Cheryl Fraser and Dr. Dirk Huyer to its Board of Directors. Dr. Francescutti has been appointed as Chair of CCSA’s Board of Directors.…
CCSA launches A Review of Workplace Substance Use Policies in Canada
Drug content monitoring is the examination of the contents of drugs from the illegal drug supply. It helps identify drug contamination and gathers information for people who use drugs to better understand what they might be taking and make more…
Ottawa, February 25, 2019 — In a brief submitted to Health Canada’s consultation on Strict regulation of edible cannabis, extracts and topicals, the Canadian Centre on Substance Use and Addiction (CCSA) cautions that edible…
Nguyen, H., Mital, S., Grootendorst, P., & Bornstein, S.
A class of medications used to treat type 2 diabetes and obesity could help treat substance use disorders. GLP-1s, made popular by brands like Ozempic and Wegovy, show real promise in helping people curb cravings for substances like alcohol and…
CCSA in partnership with Alberta Health Services has created a series of videos that look to improve understanding on:
Fundamental elements for this quadrant include:
The Community Urinalysis and Self-Report Project (CUSP) was developed and is being rolled out in multiple phases:
Doug Beirness’ career achievements derive from an interest in how alcohol and drugs affect people, especially their driving skills. He is CCSA’s leading expert on impaired driving.
Title
Institution
